Clinical Trial Update: Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study of the LEISH-F3 + SLA-SE vaccine in healthy adults has completed, evaluating safety and immunogenicity related to visceral leishmaniasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• LEISH-F3 + SLA-SE vaccine (LEISH-F3 + SLA-SE)

Snippet

Sponsor: Access to Advanced Health Institute (AAHI) | Conditions: Visceral Leishmaniasis | Phase 1 | Status: COMPLETED